NO20006312L - Terapeutiske blandinger av selektive östrogenreseptor- modulatorer (SERM) og veksthormon sekretstimulerende middel (GHS) for behandling av muskuloskjelett skjörhet - Google Patents

Terapeutiske blandinger av selektive östrogenreseptor- modulatorer (SERM) og veksthormon sekretstimulerende middel (GHS) for behandling av muskuloskjelett skjörhet

Info

Publication number
NO20006312L
NO20006312L NO20006312A NO20006312A NO20006312L NO 20006312 L NO20006312 L NO 20006312L NO 20006312 A NO20006312 A NO 20006312A NO 20006312 A NO20006312 A NO 20006312A NO 20006312 L NO20006312 L NO 20006312L
Authority
NO
Norway
Prior art keywords
ghs
serms
treatment
growth hormone
fragility
Prior art date
Application number
NO20006312A
Other languages
English (en)
Norwegian (no)
Other versions
NO20006312D0 (no
Inventor
Hua Zhu Ke
Lei Li
Lydia Codetta Pan
David Duane Thompson
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of NO20006312D0 publication Critical patent/NO20006312D0/no
Publication of NO20006312L publication Critical patent/NO20006312L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physical Education & Sports Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20006312A 1998-06-16 2000-12-12 Terapeutiske blandinger av selektive östrogenreseptor- modulatorer (SERM) og veksthormon sekretstimulerende middel (GHS) for behandling av muskuloskjelett skjörhet NO20006312L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8946998P 1998-06-16 1998-06-16
PCT/IB1999/001117 WO1999065486A1 (en) 1998-06-16 1999-06-16 Therapeutic combinations of (selective) estrogen receptor modulators (serm) and growth hormone secretagogues (ghs) for treating musculoskeletal frailty

Publications (2)

Publication Number Publication Date
NO20006312D0 NO20006312D0 (no) 2000-12-12
NO20006312L true NO20006312L (no) 2000-12-12

Family

ID=22217825

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20006312A NO20006312L (no) 1998-06-16 2000-12-12 Terapeutiske blandinger av selektive östrogenreseptor- modulatorer (SERM) og veksthormon sekretstimulerende middel (GHS) for behandling av muskuloskjelett skjörhet

Country Status (30)

Country Link
EP (1) EP1087764A1 (is)
JP (1) JP2002518326A (is)
KR (1) KR20010052852A (is)
CN (1) CN1301160A (is)
AP (1) AP9901582A0 (is)
AR (1) AR018869A1 (is)
AU (1) AU4054799A (is)
BG (1) BG105041A (is)
BR (1) BR9911324A (is)
CA (1) CA2335134A1 (is)
CO (1) CO5070587A1 (is)
EA (1) EA200001186A1 (is)
GT (1) GT199900087A (is)
HN (1) HN1999000097A (is)
HR (1) HRP20000859A2 (is)
HU (1) HUP0102505A3 (is)
ID (1) ID27599A (is)
IL (1) IL138630A0 (is)
IS (1) IS5691A (is)
MA (1) MA26652A1 (is)
NO (1) NO20006312L (is)
OA (1) OA11505A (is)
PA (1) PA8475901A1 (is)
PE (1) PE20000646A1 (is)
PL (1) PL344981A1 (is)
SK (1) SK18912000A3 (is)
TN (1) TNSN99124A1 (is)
TR (1) TR200003544T2 (is)
WO (1) WO1999065486A1 (is)
ZA (1) ZA993975B (is)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2360103A1 (en) * 1999-02-08 2000-08-17 Robert Sladek Non-human transgenic animal whose germ cells and somatic cells contain a knockout mutation in dna encoding orphan nuclear receptor erralpha
ATE346159T1 (de) 2000-05-08 2006-12-15 Pfizer Prod Inc Enzymatische spaltung von selektiven modulatoren des östrogenrezeptors
IL145106A0 (en) * 2000-08-30 2002-06-30 Pfizer Prod Inc Intermittent administration of a geowth hormone secretagogue
BR0113626A (pt) 2000-08-30 2003-06-17 Pfizer Prod Inc Formulações de liberação sustentada para secretores de hormÈnio do crescimento
US7476653B2 (en) 2003-06-18 2009-01-13 Tranzyme Pharma, Inc. Macrocyclic modulators of the ghrelin receptor
WO2006024931A2 (en) * 2004-08-31 2006-03-09 Pfizer Products Inc. Therapeutic combinations comprising a selective estrogen receptor modulator and a selective androgen receptor modulator
CU23558A1 (es) 2006-02-28 2010-07-20 Ct Ingenieria Genetica Biotech Compuestos análogos a los secretagogos peptidicos de la hormona de crecimiento
EA200901077A1 (ru) 2007-02-09 2010-04-30 Транзим Фарма, Инк. Макроциклические модуляторы грелинового рецептора и их применение

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA51676C2 (uk) * 1995-11-02 2002-12-16 Пфайзер Інк. (-)цис-6(s)-феніл-5(r)[4-(2-піролідин-1-ілетокси)феніл]-5,6,7,8-тетрагідронафталін-2-ол d-тартрат, спосіб його одержання, спосіб лікування захворювань, що піддаються лікуванню агоністами естрогену, та фармацевтична композиція
TW432073B (en) * 1995-12-28 2001-05-01 Pfizer Pyrazolopyridine compounds
HN1996000101A (es) * 1996-02-28 1997-06-26 Inc Pfizer Terapia combinada para la osteoporosis

Also Published As

Publication number Publication date
AU4054799A (en) 2000-01-05
HRP20000859A2 (en) 2001-04-30
HUP0102505A3 (en) 2002-12-28
EP1087764A1 (en) 2001-04-04
MA26652A1 (fr) 2004-12-20
CN1301160A (zh) 2001-06-27
BG105041A (en) 2001-08-31
PE20000646A1 (es) 2000-08-05
CO5070587A1 (es) 2001-08-28
TNSN99124A1 (fr) 2005-11-10
SK18912000A3 (sk) 2001-10-08
BR9911324A (pt) 2001-04-03
CA2335134A1 (en) 1999-12-23
HUP0102505A2 (hu) 2001-11-28
IL138630A0 (en) 2001-10-31
AR018869A1 (es) 2001-12-12
EA200001186A1 (ru) 2001-06-25
AP9901582A0 (en) 1999-06-30
NO20006312D0 (no) 2000-12-12
ZA993975B (en) 2000-12-15
OA11505A (en) 2004-05-07
GT199900087A (es) 2000-12-07
IS5691A (is) 2000-10-27
WO1999065486A1 (en) 1999-12-23
HN1999000097A (es) 1999-11-03
JP2002518326A (ja) 2002-06-25
KR20010052852A (ko) 2001-06-25
TR200003544T2 (tr) 2001-04-20
PL344981A1 (en) 2001-11-19
PA8475901A1 (es) 2000-05-24
ID27599A (id) 2001-04-12

Similar Documents

Publication Publication Date Title
YU18400A (sh) Prostaglanidin agonisti i njihova primena za tretiranje koštanih poremećaja
NO20040331L (no) Legemidler for sykdommer med benmassetap som har Eragonist som den aktive bestanddel
EP0911321A3 (en) Compounds for the treatment of osteoporosis
DE60037836D1 (de) ThiazoloÄ4,5-dÜpyrimidinverbindungen zur Behandlung von rheumathoider Arthritis
WO1998058911A3 (en) Prostaglandin agonists
NO20006312L (no) Terapeutiske blandinger av selektive östrogenreseptor- modulatorer (SERM) og veksthormon sekretstimulerende middel (GHS) for behandling av muskuloskjelett skjörhet
DK217588D0 (da) 17beta-(cyclopropylamino)-androst-5-en-3beta-olderivater, deres fremstilling og anvendelse som laegemidler
BG105125A (en) Therapeutic combinations comprising a selective estrogen receptor modulator and parathyroid hormone
NO20006381L (no) Terapeutiske kombinasjoner av (selektive) östrogenreseptormodulatorer (SERM) og veksthormonsekresjonsmidler
NZ504051A (en) Crystalline polymorphs of 1,3-di-cyclopropylmethyl-8-amino xanthine (cypamfylline), and the use of these compounds for treating PDE4 or TNF mediated diseases
CA2274381A1 (en) Therapeutic combinations comprising a selective estrogen receptor modulator and prostaglandin e2
ECSP993020A (es) Terapia de combinacion para la fragilidad musculoesqueletica
ECSP993021A (es) Combinaciones terapeuticas para la fragilidad musculoesqueletica
Endo et al. The intramedullary gradual elongation nail: Application for femoral shaft non-union
TODANI A follow-up study of the subtrochanteric osteotomy for the treatment of the irreducible congenital dislocation of the hip
Kojima et al. Treatment for Proximal Humeral Fractures of Elderly Patients with Spiral Pin
Ikemoto et al. Treatment of Fracture-Dislocation of the Ankle
UA28851A (uk) Спосіб оперативного лікування переломів дистального метаепіфізу великогомілкової кістки
Hajime et al. The Improvement of the Upper Extremity Function in Cerebral Palsy
Mizokami et al. Application of cast brac for fractures of the lower extremities
Fukushima et al. The Y-shaped Plate for the Fractures around the Joint
Whitman TREATMENT OF FRACTURES OF NECK OF FEMUR
TH57984A3 (th) การรวมในทางการรักษาซี่งประกอบด้วยตัวปรับตัวรับเอสโตรเจนแบบคัดเลือกและฮอร์โมนพาราไธรอยด์

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application